Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	ZNF136 ZNF845 IKZF3 IKZF2 HIVEP1 ZNF680 ZFP3 ZSCAN5DP ZNF337 ZNF569 ZNF329 ZNF205 HIC2 IKZF1 ZNF215 ZNF101 SIM1 ZNF317 ZFP69 ZNF442 ZEB2 ZNF568 IKZF4 ZFY ZNF668 CTCFL GRHL1 ZNF773 GZF1 ZNF69 ZNF432 ZNF624 ZFHX3 ZNF350 ZNF528 ZNF615 ZNF30 ZNF700 ZNF564 ZNF709 ZNF726	7.06e-14	1459	150	41	GO:0000977
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	ZNF136 ZNF845 IKZF3 HIVEP1 ZNF680 ZFP3 ZSCAN5DP ZNF337 ZNF569 ZNF329 ZNF205 HIC2 IKZF1 ZNF215 ZNF101 SIM1 ZNF317 ZFP69 ZNF442 ZEB2 ZNF568 ZFY ZNF668 CTCFL GRHL1 ZNF773 GZF1 ZBTB40 ZNF69 ZNF432 ZNF624 ZFHX3 ZNF350 ZNF528 ZNF615 ZNF30 ZNF700 ZNF709 MYRF ZNF726	1.20e-13	1412	150	40	GO:0000981
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	ZNF136 ZNF845 IKZF3 IKZF2 HIVEP1 ZNF680 ZFP3 ZSCAN5DP ZNF569 ZNF205 HIC2 IKZF1 ZNF215 ZNF101 ZNF317 ZEB2 ZNF568 IKZF4 ZFY ZNF668 CTCFL GRHL1 ZNF773 GZF1 ZNF432 ZNF624 ZFHX3 ZNF350 ZNF528 ZNF615 ZNF30 ZNF564 ZNF709 ZNF726	3.34e-11	1244	150	34	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	ZNF136 ZNF845 IKZF3 IKZF2 HIVEP1 ZNF680 ZFP3 ZSCAN5DP ZNF569 ZNF205 HIC2 IKZF1 ZNF215 ZNF101 ZNF317 ZEB2 ZNF568 IKZF4 ZFY ZNF668 CTCFL GRHL1 ZNF773 GZF1 ZNF432 ZNF624 ZFHX3 ZNF350 ZNF528 ZNF615 ZNF30 ZNF564 ZNF709 ZNF726	5.95e-11	1271	150	34	GO:0000987
GeneOntologyMolecularFunction	DNA-binding transcription repressor activity, RNA polymerase II-specific	HIVEP1 ZFP3 ZNF205 HIC2 IKZF1 ZNF101 ZEB2 ZNF668 GZF1 ZFHX3 ZNF350 ZNF709 ZNF726	9.24e-07	320	150	13	GO:0001227
GeneOntologyMolecularFunction	DNA-binding transcription repressor activity	HIVEP1 ZFP3 ZNF205 HIC2 IKZF1 ZNF101 ZEB2 ZNF668 GZF1 ZFHX3 ZNF350 ZNF709 ZNF726	1.14e-06	326	150	13	GO:0001217
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	ZNF845 IKZF3 ZNF101 ZEB2 ZFY ZNF668 CTCFL GRHL1 GZF1 ZNF624 ZNF615 ZNF709 ZNF726	3.18e-04	560	150	13	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	ZNF845 IKZF3 ZNF101 ZEB2 ZFY ZNF668 CTCFL GRHL1 GZF1 ZNF624 ZNF615 ZNF709 ZNF726	3.52e-04	566	150	13	GO:0001216
GeneOntologyCellularComponent	axolemma	ANK1 SPTBN1 EPB41L3 SLC1A2	1.39e-05	21	150	4	GO:0030673
GeneOntologyCellularComponent	A band	MYH1 ANK1 SPTBN1 RYR2 RPL15	3.52e-05	52	150	5	GO:0031672
GeneOntologyCellularComponent	main axon	ANK1 MAP2 SPTBN1 DBH EPB41L3 SLC1A2	4.40e-05	89	150	6	GO:0044304
GeneOntologyCellularComponent	muscle myosin complex	MYH1 MYH4 MYH8	1.89e-04	16	150	3	GO:0005859
GeneOntologyCellularComponent	sarcomere	MYH1 MYH4 MYH8 ANK1 SPTBN1 RYR2 SYNE2 RPL15	4.45e-04	249	150	8	GO:0030017
GeneOntologyCellularComponent	myosin filament	MYH1 MYH4 MYH8	7.42e-04	25	150	3	GO:0032982
GeneOntologyCellularComponent	myofibril	MYH1 MYH4 MYH8 ANK1 SPTBN1 RYR2 SYNE2 RPL15	8.14e-04	273	150	8	GO:0030016
GeneOntologyCellularComponent	actin cytoskeleton	MYH1 MYH4 MYH8 SHROOM3 MAP2 SPTBN1 CIT MPRIP PTPN11 SCNN1D COBL EPB41L2	9.37e-04	576	150	12	GO:0015629
GeneOntologyCellularComponent	myosin II complex	MYH1 MYH4 MYH8	1.04e-03	28	150	3	GO:0016460
GeneOntologyCellularComponent	contractile muscle fiber	MYH1 MYH4 MYH8 ANK1 SPTBN1 RYR2 SYNE2 RPL15	1.20e-03	290	150	8	GO:0043292
MousePheno	abnormal cell nucleus morphology	ERCC4 CEP290 MCM2 RECQL PTPN11 LATS2 BRCA2 SYNE2 BUB1B VCPIP1	1.31e-06	184	106	10	MP:0003111
MousePheno	abnormal intracellular organelle morphology	ERCC4 CEP290 MCM2 RECQL RYR2 FAH PTPN11 LATS2 BRCA2 SYNE2 BUB1B PKP2 COBL PISD VCPIP1	1.51e-05	546	106	15	MP:0014239
MousePheno	abnormal chromosome stability	ZSCAN5DP MCM2 RECQL LATS2 BRCA2 BUB1B VCPIP1	2.64e-05	115	106	7	MP:0010094
Domain	Znf_C2H2/integrase_DNA-bd	ZNF136 ZNF845 IKZF3 IKZF2 HIVEP1 ZNF680 ZFP3 ZSCAN5DP ZNF337 ZNF569 ZNF329 ZNF205 HIC2 IKZF1 ZNF215 ZNF101 ZNF317 ZFP69 ZNF442 ZEB2 ZNF568 IKZF4 ZFY ZNF668 CTCFL ZNF773 GZF1 ZFP91 ZBTB40 ZNF69 ZNF432 ZNF624 ZFHX3 ZNF350 ZNF528 ZNF615 ZNF30 ZNF700 ZNF564 ZNF709 ZNF726	1.10e-24	694	148	41	IPR013087
Domain	-	ZNF136 ZNF845 IKZF3 IKZF2 HIVEP1 ZNF680 ZFP3 ZNF337 ZNF569 ZNF329 ZNF205 HIC2 IKZF1 ZNF215 ZNF101 ZNF317 ZFP69 ZNF442 ZEB2 ZNF568 IKZF4 ZFY ZNF668 CTCFL ZNF773 GZF1 ZFP91 ZBTB40 ZNF69 ZNF432 ZNF624 ZFHX3 ZNF350 ZNF528 ZNF615 ZNF30 ZNF700 ZNF564 ZNF709 ZNF726	5.10e-24	679	148	40	3.30.160.60
Domain	zf-C2H2	ZNF136 ZNF845 IKZF3 IKZF2 HIVEP1 ZNF680 ZFP3 ZSCAN5DP ZNF337 ZNF569 ZNF329 ZNF205 HIC2 IKZF1 ZNF215 ZNF101 ZNF317 ZFP69 ZNF442 ZNF568 IKZF4 ZFY ZNF668 CTCFL ZNF773 GZF1 ZFP91 ZBTB40 ZNF69 ZNF432 ZNF624 ZFHX3 ZNF350 ZNF528 ZNF615 ZNF30 ZNF700 ZNF564 ZNF709 ZNF726	1.09e-23	693	148	40	PF00096
Domain	Znf_C2H2	ZNF136 ZNF845 IKZF3 IKZF2 HIVEP1 ZNF680 ZFP3 ZSCAN5DP ZNF337 ZNF569 ZNF329 ZNF205 HIC2 IKZF1 ZNF215 ZNF101 ZNF317 ZFP69 ZNF442 ZEB2 ZNF568 IKZF4 ZFY ZNF668 CTCFL ZNF773 GTF2H2 GZF1 ZFP91 ZBTB40 ZNF69 ZNF432 ZNF624 ZFHX3 ZNF350 ZNF528 ZNF615 ZNF30 ZNF700 ZNF564 ZNF709 ZNF726	3.27e-23	805	148	42	IPR007087
Domain	ZINC_FINGER_C2H2_2	ZNF136 ZNF845 IKZF3 IKZF2 HIVEP1 ZNF680 ZFP3 ZSCAN5DP ZNF337 ZNF569 ZNF329 ZNF205 HIC2 IKZF1 ZNF215 ZNF101 ZNF317 ZFP69 ZNF442 ZEB2 ZNF568 IKZF4 ZFY ZNF668 CTCFL ZNF773 GZF1 ZFP91 ZBTB40 ZNF69 ZNF432 ZNF624 ZFHX3 ZNF350 ZNF528 ZNF615 ZNF30 ZNF700 ZNF564 ZNF709 ZNF726	7.23e-23	775	148	41	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF136 ZNF845 IKZF3 IKZF2 HIVEP1 ZNF680 ZFP3 ZSCAN5DP ZNF337 ZNF569 ZNF329 ZNF205 HIC2 IKZF1 ZNF215 ZNF101 ZNF317 ZFP69 ZNF442 ZEB2 ZNF568 IKZF4 ZFY ZNF668 CTCFL ZNF773 GZF1 ZFP91 ZBTB40 ZNF69 ZNF432 ZNF624 ZFHX3 ZNF350 ZNF528 ZNF615 ZNF30 ZNF700 ZNF564 ZNF709 ZNF726	7.96e-23	777	148	41	PS00028
Domain	Znf_C2H2-like	ZNF136 ZNF845 IKZF3 IKZF2 HIVEP1 ZNF680 ZFP3 ZSCAN5DP ZNF337 ZNF569 ZNF329 ZNF205 HIC2 IKZF1 ZNF215 ZNF101 ZNF317 ZFP69 ZNF442 ZEB2 ZNF568 IKZF4 ZFY ZNF668 CTCFL ZNF773 GZF1 ZFP91 ZBTB40 ZNF69 ZNF432 ZNF624 ZFHX3 ZNF350 ZNF528 ZNF615 ZNF30 ZNF700 ZNF564 ZNF709 ZNF726	1.97e-22	796	148	41	IPR015880
Domain	ZnF_C2H2	ZNF136 ZNF845 IKZF3 IKZF2 HIVEP1 ZNF680 ZFP3 ZSCAN5DP ZNF337 ZNF569 ZNF329 ZNF205 HIC2 IKZF1 ZNF215 ZNF101 ZNF317 ZFP69 ZNF442 ZEB2 ZNF568 IKZF4 ZFY ZNF668 CTCFL ZNF773 GZF1 ZFP91 ZBTB40 ZNF69 ZNF432 ZNF624 ZFHX3 ZNF350 ZNF528 ZNF615 ZNF30 ZNF700 ZNF564 ZNF709 ZNF726	3.45e-22	808	148	41	SM00355
Domain	KRAB	ZNF136 ZNF845 ZNF680 ZNF337 ZNF569 ZNF205 ZNF215 ZNF101 ZNF317 ZFP69 ZNF442 ZNF568 ZNF773 ZNF69 ZNF432 ZNF624 ZNF350 ZNF528 ZNF615 ZNF30 ZNF700 ZNF564 ZNF709 ZNF726	8.87e-16	358	148	24	PS50805
Domain	KRAB	ZNF136 ZNF845 ZNF680 ZNF337 ZNF569 ZNF205 ZNF215 ZNF101 ZNF317 ZFP69 ZNF442 ZNF568 ZNF773 ZNF69 ZNF432 ZNF624 ZNF350 ZNF528 ZNF615 ZNF30 ZNF700 ZNF564 ZNF709 ZNF726	8.87e-16	358	148	24	PF01352
Domain	KRAB	ZNF136 ZNF845 ZNF680 ZNF337 ZNF569 ZNF205 ZNF215 ZNF101 ZNF317 ZFP69 ZNF442 ZNF568 ZNF773 ZNF69 ZNF432 ZNF624 ZNF350 ZNF528 ZNF615 ZNF30 ZNF700 ZNF564 ZNF709 ZNF726	1.75e-15	369	148	24	SM00349
Domain	KRAB	ZNF136 ZNF845 ZNF680 ZNF337 ZNF569 ZNF205 ZNF215 ZNF101 ZNF317 ZFP69 ZNF442 ZNF568 ZNF773 ZNF69 ZNF432 ZNF624 ZNF350 ZNF528 ZNF615 ZNF30 ZNF700 ZNF564 ZNF709 ZNF726	1.86e-15	370	148	24	IPR001909
Domain	zf-C2H2_6	ZNF136 ZNF845 ZNF680 ZNF569 ZNF329 ZNF317 ZNF442 ZNF568 ZNF668 ZNF773 GZF1 ZNF69 ZNF432 ZNF624 ZNF615 ZNF30 ZNF700 ZNF564 ZNF709 ZNF726	6.96e-13	314	148	20	PF13912
Domain	L_AA_transporter	SLC7A11 SLC7A8	1.86e-04	3	148	2	IPR004760
Domain	Myosin_N	MYH1 MYH4 MYH8	2.07e-04	15	148	3	PF02736
Domain	Myosin_N	MYH1 MYH4 MYH8	2.07e-04	15	148	3	IPR004009
Domain	Myosin_tail_1	MYH1 MYH4 MYH8	3.65e-04	18	148	3	PF01576
Domain	Myosin_tail	MYH1 MYH4 MYH8	3.65e-04	18	148	3	IPR002928
Domain	4_1_CTD	EPB41L3 EPB41L2	3.70e-04	4	148	2	PF05902
Domain	SAB	EPB41L3 EPB41L2	3.70e-04	4	148	2	PF04382
Domain	Band_4.1_C	EPB41L3 EPB41L2	3.70e-04	4	148	2	IPR008379
Domain	SAB_dom	EPB41L3 EPB41L2	3.70e-04	4	148	2	IPR007477
Domain	Myosin-like_IQ_dom	MYH1 MYH4 MYH8	4.30e-04	19	148	3	IPR027401
Domain	-	MYH1 MYH4 MYH8	4.30e-04	19	148	3	4.10.270.10
Domain	FERM_PH-like_C	EPB41L3 FRMD1 EPB41L2	1.24e-03	27	148	3	IPR018980
Domain	FERM_C	EPB41L3 FRMD1 EPB41L2	1.24e-03	27	148	3	SM01196
Pathway	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION	ZNF136 ZNF680 ZNF337 ZNF569 ZNF205 ZNF215 ZNF101 ZNF317 ZFP69 ZNF442 ZNF568 ZNF668 PTPN11 ZNF773 GTF2H2 SERPINB13 ZNF432 ZNF624 ZFHX3 ZNF350 ZNF528 ZNF615 ZNF30 ZNF700 ZNF564 ZNF709 ZNF726	1.66e-05	1387	116	27	M734
Pubmed	Acetylation-Mimic Mutation of TRIM28-Lys304 to Gln Attenuates the Interaction with KRAB-Zinc-Finger Proteins and Affects Gene Expression in Leukemic K562 Cells.	ZNF136 ZNF845 ZNF680 ZNF569 ZNF101 ZNF317 ZNF432 ZNF624 ZNF615 ZNF564 ZNF726	5.12e-10	181	152	11	37372979
Pubmed	Eos and pegasus, two members of the Ikaros family of proteins with distinct DNA binding activities.	IKZF3 IKZF2 IKZF1 IKZF4	1.75e-09	5	152	4	10978333
Pubmed	Emergence of the ZNF91 Krüppel-associated box-containing zinc finger gene family in the last common ancestor of anthropoidea.	ZNF569 ZNF317 ZFP69 ZNF624 ZNF726	2.19e-08	20	152	5	7479878
Pubmed	Activation of the c-H-ras proto-oncogene by retrovirus insertion and chromosomal rearrangement in a Moloney leukemia virus-induced T-cell leukemia.	ZNF569 ZNF317 ZFP69 ZNF624 ZNF726	2.19e-08	20	152	5	2542606
Pubmed	Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors.	IKZF3 IKZF2 IKZF1	8.18e-08	3	152	3	9560339
Pubmed	Analysis of Ikaros family splicing variants in human hematopoietic lineages.	IKZF3 IKZF2 IKZF1	8.18e-08	3	152	3	20432734
Pubmed	Aberrant Ikaros, Aiolos, and Helios expression in Hodgkin and non-Hodgkin lymphoma.	IKZF3 IKZF2 IKZF1	8.18e-08	3	152	3	18332232
Pubmed	Overexpression of novel short isoforms of Helios in a patient with T-cell acute lymphoblastic leukemia.	IKZF3 IKZF2 IKZF1	8.18e-08	3	152	3	11937265
Pubmed	Expression patterns of Ikaros family members during positive selection and lineage commitment of human thymocytes.	IKZF3 IKZF2 IKZF1	8.18e-08	3	152	3	27502439
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SHROOM3 HIVEP1 MAP2 SPTBN1 EPB41L3 MPRIP CEP170 SBF1 SYNE2 EIF4G1 BUB1B PKP2 COBL GIGYF2 GNAS EPB41L2 VCPIP1	2.55e-07	861	152	17	36931259
Pubmed	Three linked myosin heavy chain genes clustered within 370 kb of each other show independent transcriptional and post-transcriptional regulation during differentiation of a mouse muscle cell line.	MYH1 MYH4 MYH8	3.26e-07	4	152	3	1985022
Pubmed	A molecular dissection of the repression circuitry of Ikaros.	IKZF3 IKZF2 IKZF1 IKZF4	3.39e-07	14	152	4	12015313
Pubmed	Disruption of 14-3-3 binding does not impair Protein 4.1B growth suppression.	SPTBN1 EPB41L3 EPB41L2	8.13e-07	5	152	3	15116094
Pubmed	Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro.	MYH1 MYH4 MYH8	8.13e-07	5	152	3	3829126
Pubmed	Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development.	MYH1 MYH4 MYH8	8.13e-07	5	152	3	12919077
Pubmed	Sequential accumulation of mRNAs encoding different myosin heavy chain isoforms during skeletal muscle development in vivo detected with a recombinant plasmid identified as coding for an adult fast myosin heavy chain from mouse skeletal muscle.	MYH1 MYH4 MYH8	8.13e-07	5	152	3	6196357
Pubmed	Human transcription factor protein interaction networks.	IKZF3 HIVEP1 ERCC4 RARS1 PITRM1 SPTBN1 HIC2 CIT ZEB2 MPRIP KANSL3 KANSL1 SYNE2 ZFP91 EIF4G1 ZBTB40 GIGYF2 ZFHX3 LTV1 KDM1B ZNF709	1.19e-06	1429	152	21	35140242
Pubmed	Ikaros promotes early-born neuronal fates in the cerebral cortex.	IKZF3 IKZF2 IKZF1 IKZF4	1.29e-06	19	152	4	23382203
Pubmed	Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN.	HIC2 IKZF1 GZF1 ZFP91	1.29e-06	19	152	4	30385546
Pubmed	Distinct myogenic programs of embryonic and fetal mouse muscle cells: expression of the perinatal myosin heavy chain isoform in vitro.	MYH1 MYH4 MYH8	1.62e-06	6	152	3	1728586
Pubmed	Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved.	MYH1 MYH4 MYH8	1.62e-06	6	152	3	10077619
Pubmed	Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development.	MYH1 MYH4 MYH8	1.62e-06	6	152	3	10588881
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	RARS1 ATG2B ABCF2 CEP170 EIF4G1 BUB1B GIGYF2 EPB41L2 VCPIP1	2.07e-06	256	152	9	33397691
Pubmed	Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR.	ZNF569 ZNF101 ZNF317 ZNF624 ZNF726	2.44e-06	49	152	5	9630514
Pubmed	A fast Myosin super enhancer dictates muscle fiber phenotype through competitive interactions with Myosin genes.	MYH1 MYH4 MYH8	2.83e-06	7	152	3	35210422
Pubmed	Diversity in transcriptional start site selection and alternative splicing affects the 5'-UTR of mouse striated muscle myosin transcripts.	MYH1 MYH4 MYH8	2.83e-06	7	152	3	16819597
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	SPTBN1 ATG2B ABCF2 EPB41L3 CEP170 PTPN11 EIF4G1 BUB1B PKP2 GIGYF2 LTV1 EPB41L2 RPL15 VCPIP1	3.04e-06	708	152	14	39231216
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	DNHD1 HIVEP1 RARS1 PITRM1 SPTBN1 ZNF329 MCM2 RECQL ABCF2 SAMHD1 IDH3G EPB41L3 PTPN11 EIF4G1 GIGYF2 LTV1 GNAS EPB41L2 MGAM2 RPL15	4.35e-06	1425	152	20	30948266
Pubmed	Genes for skeletal muscle myosin heavy chains are clustered and are not located on the same mouse chromosome as a cardiac myosin heavy chain gene.	MYH1 MYH4 MYH8	4.51e-06	8	152	3	3864153
Pubmed	Control of TurboID-dependent biotinylation intensity in proximity ligation screens.	MIA3 ATG2B CIT SLC7A11 UGGT2 VCPIP1	5.36e-06	100	152	6	36966971
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	CEP290 ATG2B RECQL CCDC77 EPB41L3 WDR76 CEP170 PTPN11 NDC80 ZFP91 BUB1B KDM1B VCPIP1	5.66e-06	645	152	13	25281560
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	ZNF845 MIA3 ERCC4 RARS1 CTSC SPTBN1 ZNF329 ZNF205 ABCF2 ZNF317 SLC7A11 ZNF668 ZNF773 GZF1 NDC80 EIF4G1 GNAS RPL15	5.74e-06	1203	152	18	29180619
Pubmed	Myh7b/miR-499 gene expression is transcriptionally regulated by MRFs and Eos.	IKZF2 IKZF1 IKZF4	6.74e-06	9	152	3	22638570
Pubmed	Helios transcription factor expression depends on Gsx2 and Dlx1&2 function in developing striatal matrix neurons.	IKZF2 MAP2 IKZF1	6.74e-06	9	152	3	22142223
Pubmed	The functional landscape of Hsp27 reveals new cellular processes such as DNA repair and alternative splicing and proposes novel anticancer targets.	ANK1 SPTBN1 EPB41L3 KANSL1 SBF1 MTIF2 OSBPL9 EPB41L2	7.14e-06	225	152	8	25277244
Pubmed	Chromosomal location of fifteen unique mouse KRAB-containing zinc finger loci.	ZNF569 ZNF317 ZFP69 ZNF624 ZNF726	7.29e-06	61	152	5	8662221
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	ANK1 MAP2 SPTBN1 EPB41L3 CIT MPRIP EPB41L2 VCPIP1	8.65e-06	231	152	8	16452087
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	RARS1 CTSC SPTBN1 SAMHD1 CCDC77 WDR76 MPRIP KANSL3 CEP170 GTF2H2 GZF1 ZFP91 EIF4G1 PKP2 LTV1 GNAS RBM47 EPB41L2 RPL15	9.21e-06	1371	152	19	36244648
Pubmed	During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation.	MYH1 MYH4 MYH8	9.60e-06	10	152	3	19506036
Pubmed	A human MAP kinase interactome.	HIVEP1 RPS6KA5 SPTBN1 CEP290 LAMA3 EPB41L3 SLC1A2 KANSL1 COBL GIGYF2 EPB41L2	1.05e-05	486	152	11	20936779
Pubmed	Modulation of contractile protein gene expression in fetal murine crural muscles: emergence of muscle diversity.	MYH1 MYH4 MYH8	1.32e-05	11	152	3	8136524
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	IKZF2 HIVEP1 RARS1 SPTBN1 CEP290 ZNF205 HIC2 IDH3G ZNF568 RIN2 EIF4G1 GIGYF2 PISD TUBD1 EPB41L2	1.43e-05	925	152	15	28986522
Pubmed	Regulation of gene expression dynamics during developmental transitions by the Ikaros transcription factor.	IKZF1 IKZF4	1.90e-05	2	152	2	26314708
Pubmed	Helios deficiency has minimal impact on T cell development and function.	IKZF2 IKZF1	1.90e-05	2	152	2	19620299
Pubmed	Loss of Ikaros DNA-binding function confers integrin-dependent survival on pre-B cells and progression to acute lymphoblastic leukemia.	IKZF3 IKZF1	1.90e-05	2	152	2	24509510
Pubmed	Role of Aiolos and Ikaros in the Antitumor and Immunomodulatory Activity of IMiDs in Multiple Myeloma: Better to Lose Than to Find Them.	IKZF3 IKZF1	1.90e-05	2	152	2	33499314
Pubmed	COBL is a novel hotspot for IKZF1 deletions in childhood acute lymphoblastic leukemia.	IKZF1 COBL	1.90e-05	2	152	2	27419633
Pubmed	Genetic mapping and allelic loss analysis in mouse thymic lymphomas of Helios and Aiolos belonging to the Ikaros gene family.	IKZF3 IKZF2	1.90e-05	2	152	2	11173542
Pubmed	Growth and muscle defects in mice lacking adult myosin heavy chain genes.	MYH1 MYH4	1.90e-05	2	152	2	9382868
Pubmed	Postnatal myosin heavy chain isoform expression in normal mice and mice null for IIb or IId myosin heavy chains.	MYH1 MYH4	1.90e-05	2	152	2	11150240
Pubmed	An epigenetic regulator emerges as microtubule minus-end binding and stabilizing factor in mitosis.	KANSL3 KANSL1	1.90e-05	2	152	2	26243146
Pubmed	Suppression of Aiolos and Ikaros expression by lenalidomide reduces human ILC3-ILC1/NK cell transdifferentiation.	IKZF3 IKZF1	1.90e-05	2	152	2	31151137
Pubmed	Impaired tissue homing by the Ikzf3N159S variant is mediated by interfering with Ikaros function.	IKZF3 IKZF1	1.90e-05	2	152	2	37662955
Pubmed	Potential role of BRCA2 in a mitotic checkpoint after phosphorylation by hBUBR1.	BRCA2 BUB1B	1.90e-05	2	152	2	10749118
Pubmed	Critical function of Ikaros in controlling Aiolos gene expression.	IKZF3 IKZF1	1.90e-05	2	152	2	17383641
Pubmed	High IKZF1/3 protein expression is a favorable prognostic factor for survival of relapsed/refractory multiple myeloma patients treated with lenalidomide.	IKZF3 IKZF1	1.90e-05	2	152	2	27881177
Pubmed	Association between phosphatase related gene variants and coronary artery disease: case-control study and meta-analysis.	ACP1 PTPN11	1.90e-05	2	152	2	25123136
Pubmed	Overcoming IMiD resistance in T-cell lymphomas through potent degradation of ZFP91 and IKZF1.	IKZF1 ZFP91	1.90e-05	2	152	2	34936696
Pubmed	Protein 4.1B contributes to the organization of peripheral myelinated axons.	SPTBN1 EPB41L3	1.90e-05	2	152	2	21966409
Pubmed	Cytotoxic Programming of CD4+ T Cells Is Regulated by Opposing Actions of the Related Transcription Factors Eos and Aiolos.	IKZF3 IKZF4	1.90e-05	2	152	2	38363226
Pubmed	IKZF1/3 and CRL4CRBN E3 ubiquitin ligase mutations and resistance to immunomodulatory drugs in multiple myeloma.	IKZF3 IKZF1	1.90e-05	2	152	2	31558666
Pubmed	A variant in human AIOLOS impairs adaptive immunity by interfering with IKAROS.	IKZF3 IKZF1	1.90e-05	2	152	2	34155405
Pubmed	Lipid-binding role of betaII-spectrin ankyrin-binding domain.	ANK1 SPTBN1	1.90e-05	2	152	2	17716929
Pubmed	Eos: a novel member of the Ikaros gene family expressed predominantly in the developing nervous system.	IKZF1 IKZF4	1.90e-05	2	152	2	10218586
Pubmed	Five skeletal myosin heavy chain genes are organized as a multigene complex in the human genome.	MYH4 MYH8	1.90e-05	2	152	2	8518795
Pubmed	Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation.	IKZF3 IKZF1	1.90e-05	2	152	2	9155026
Pubmed	Trans-Ancestral Fine-Mapping and Epigenetic Annotation as Tools to Delineate Functionally Relevant Risk Alleles at IKZF1 and IKZF3 in Systemic Lupus Erythematosus.	IKZF3 IKZF1	1.90e-05	2	152	2	33182226
Pubmed	CD4+ regulatory T cells lacking Helios and Eos.	IKZF2 IKZF4	1.90e-05	2	152	2	37413709
Pubmed	Predominant interaction of both Ikaros and Helios with the NuRD complex in immature thymocytes.	IKZF2 IKZF1	1.90e-05	2	152	2	17681952
Pubmed	[Expression characteristics of isoforms of Ikaros and Helios in patients with leukemia and their mechanism].	IKZF2 IKZF1	1.90e-05	2	152	2	22931634
Pubmed	Skeletal muscle adaptations in response to voluntary wheel running in myosin heavy chain null mice.	MYH1 MYH4	1.90e-05	2	152	2	11744674
Pubmed	Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles.	MYH1 MYH4 MYH8	2.27e-05	13	152	3	8404542
Pubmed	Ikaros confers early temporal competence to mouse retinal progenitor cells.	IKZF2 IKZF1 IKZF4	2.27e-05	13	152	3	18940586
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	SHROOM3 MIA3 SPTBN1 EPB41L3 CIT SLC1A2 ZEB2 MPRIP CEP170 SBF1 SYNE2 EIF4G1 STRN4 GIGYF2 EPB41L2	2.28e-05	963	152	15	28671696
Pubmed	Defective excitation-contraction coupling is partially responsible for impaired contractility in hindlimb muscles of Stac3 knockout mice.	MYH1 MYH4 MYH8	2.88e-05	14	152	3	27184118
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	FBLL1 RARS1 ATG2B MPRIP CEP170 PTPN11 BUB1B STRN4 OSBPL9 GIGYF2 VCPIP1	3.21e-05	549	152	11	38280479
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	HIVEP1 RPS6KA5 SPTBN1 TATDN2 MCM2 KANSL3 KANSL1 ZFP91 EIF4G1 ZBTB40 GIGYF2 EPB41L2 VCPIP1	3.82e-05	774	152	13	15302935
Pubmed	Assessment of a polymorphism of SDK1 with hypertension in Japanese Individuals.	PITRM1 LAMA3 DBH SLC7A8 SBF1 UGGT2	3.96e-05	142	152	6	19851296
Pubmed	Association of genetic variants with hemorrhagic stroke in Japanese individuals.	PITRM1 LAMA3 DBH SLC7A8 SBF1 UGGT2	4.12e-05	143	152	6	20198315
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	MIA3 KCNH7 RARS1 MAP2 SPTBN1 ATG2B IDH3G EPB41L3 CIT SLC1A2 RYR2 CEP170 STRN4 EPB41L2 RPL15 VCPIP1	4.18e-05	1139	152	16	36417873
Pubmed	Mitochondrial Raf1 Regulates Glutamine Catabolism.	SAMD9 CTSC EPB41L3 CIT CEP170 LATS2 PKP2 GNAS	4.20e-05	288	152	8	38496616
Pubmed	Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.	MIA3 SPTBN1 ATG2B EPB41L3 CEP170 PTPN11 SYNE2 EIF4G1 OSBPL9 GIGYF2 VCPIP1	4.36e-05	568	152	11	37774976
Pubmed	Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.	ATG2B EPB41L3 EIF4G1 STRN4 GIGYF2 ZNF30 EPB41L2	4.74e-05	215	152	7	35973513
Pubmed	Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation.	MYH1 MYH4	5.68e-05	3	152	2	26059207
Pubmed	Simultaneous loss of skeletal muscle myosin heavy chain IIx and IIb causes severe skeletal muscle hypoplasia in postnatal mice.	MYH1 MYH4	5.68e-05	3	152	2	36515178
Pubmed	SAMHD1 Posttranscriptionally Controls the Expression of Foxp3 and Helios in Human T Regulatory Cells.	IKZF2 SAMHD1	5.68e-05	3	152	2	30104243
Pubmed	Protein 4.1 expression in the developing hair cells of the mouse inner ear.	EPB41L3 EPB41L2	5.68e-05	3	152	2	19853587
Pubmed	Impaired phosphorylation and mis-localization of Bub1 and BubR1 are responsible for the defective mitotic checkpoint function in Brca2-mutant thymic lymphomas.	BRCA2 BUB1B	5.68e-05	3	152	2	14646599
Pubmed	Essential function of protein 4.1G in targeting of membrane protein palmitoylated 6 into Schmidt-Lanterman incisures in myelinated nerves.	EPB41L3 EPB41L2	5.68e-05	3	152	2	22025680
Pubmed	Structural Basis of Diverse Homophilic Recognition by Clustered α- and β-Protocadherins.	PCDHA9 PCDHA7	5.68e-05	3	152	2	27161523
Pubmed	Arginine Methylation by PRMT2 Controls the Functions of the Actin Nucleator Cobl.	MAP2 COBL	5.68e-05	3	152	2	29689199
Pubmed	Hedgehog signaling pathway and gastric cancer.	DISP3 DISP1	5.68e-05	3	152	2	16258256
Pubmed	Prevalence of arrhythmia-associated gene mutations and risk of sudden cardiac death in the Finnish population.	RYR2 PKP2	5.68e-05	3	152	2	23651034
Pubmed	Dopaminergic polymorphisms in Tourette syndrome: association with the DAT gene (SLC6A3).	ACP1 DBH	5.68e-05	3	152	2	17171650
Pubmed	The genomic landscape of hypodiploid acute lymphoblastic leukemia.	IKZF3 IKZF2	5.68e-05	3	152	2	23334668
Pubmed	Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).	ERCC4 BRCA2	5.68e-05	3	152	2	19920816
Pubmed	DNA damage induced by topoisomerase inhibitors activates SAMHD1 and blocks HIV-1 infection of macrophages.	MCM2 SAMHD1	5.68e-05	3	152	2	29084722
Pubmed	MOF Acetyl Transferase Regulates Transcription and Respiration in Mitochondria.	KANSL3 KANSL1	5.68e-05	3	152	2	27768893
Pubmed	The CD8alpha gene locus is regulated by the Ikaros family of proteins.	IKZF3 IKZF1	5.68e-05	3	152	2	12504015
Pubmed	Isoforms of protein 4.1 are differentially distributed in heart muscle cells: relation of 4.1R and 4.1G to components of the Ca2+ homeostasis system.	EPB41L3 EPB41L2	5.68e-05	3	152	2	22429617
Cytoband	19p13.2	ZNF136 ZNF442 ZNF69 ZNF700 ZNF564 ZNF709	1.22e-04	229	152	6	19p13.2
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF136 ZNF845 IKZF3 IKZF2 HIVEP1 ZNF680 ZFP3 ZSCAN5DP ZNF337 ZNF569 ZNF329 ZNF205 HIC2 IKZF1 ZNF215 ZNF101 ZNF317 ZFP69 ZNF442 ZEB2 ZNF568 IKZF4 ZFY ZNF668 CTCFL ZNF773 GZF1 ZFP91 ZBTB40 ZNF69 ZNF432 ZNF624 ZFHX3 ZNF350 ZNF528 ZNF615 ZNF30 ZNF700 ZNF564 ZNF709 ZNF726	6.38e-28	718	118	41	28
GeneFamily	Myosin heavy chains	MYH1 MYH4 MYH8	1.16e-04	15	118	3	1098
GeneFamily	Erythrocyte membrane protein band 4.1\|FERM domain containing	EPB41L3 EPB41L2	2.51e-04	4	118	2	951
GeneFamily	Zinc fingers SWIM-type\|Mitogen-activated protein kinase kinase kinases	ZSWIM5 ZSWIM6	1.48e-03	9	118	2	90
GeneFamily	Maestro heat like repeat containing	MROH2B MROH7	2.24e-03	11	118	2	636
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZEB2 ZFHX3	4.20e-03	15	118	2	529
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	EPB41L3 FRMD1 EPB41L2	4.25e-03	50	118	3	1293
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	SAMD9 RARS1 ACP1 MCM2 RECQL ZNF317 PPWD1 SLC7A11 PTPN11 GTF2H2 NDC80 BRCA2 EIF4G1 BUB1B UGGT2 ZNF700	4.85e-06	721	152	16	M10237
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_100	ERCC4 CPB2 SIM1 KANSL1 PKHD1 RBM47	2.10e-05	81	147	6	gudmap_developingKidney_e15.5_anlage of loop of Henle_100
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-vs-F_top274_274	MYH8 IKZF2 MAP2 PPWD1 ZEB2 CEP170 GRHL1 ZFP91 VCPIP1	7.58e-05	256	147	9	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	ZNF845 CEP290 HEATR5A ZSWIM6 ZNF317 WDR76 CIT ZEB2 GTF2H2 NDC80 BRCA2 DISP3 GIGYF2	8.67e-05	532	147	13	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000	SPTBN1 CIT ZEB2 IKZF4 CEP170 KANSL1 SYNE2 EIF4G1 GIGYF2 EPB41L2	8.72e-05	323	147	10	gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000	IKZF2 MAP2 LAMA3 CPB2 SIM1 EPB41L3 ZEB2 CEP170 SYT16 LATS2 KANSL1 SLC15A2 ZFP91 GIGYF2 INSYN2B ZFHX3	8.81e-05	769	147	16	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_200	ERCC4 CPB2 SIM1 KANSL1 ZFP91 PKHD1 RBM47	1.05e-04	155	147	7	gudmap_developingKidney_e15.5_anlage of loop of Henle_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_top-relative-expression-ranked_1000	MYH8 IKZF2 ERCC4 LAMA3 CPB2 SIM1 GRHL1 KANSL1 SLC15A2 ZFP91 PKHD1 PKP2 COBL GIGYF2 ZFHX3 RBM47	1.10e-04	784	147	16	gudmap_developingLowerUrinaryTract_e15.5_urothelium_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500	SIM1 SLC15A2 ZFP91 INSYN2B ZFHX3	1.43e-04	72	147	5	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k2
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000	RPS6KA5 SPTBN1 CEP290 ABCF2 CIT ZEB2 RYR2 IKZF4 KANSL1 SYNE2 EIF4G1 GIGYF2 INSYN2B ZFHX3 EPB41L2 VCPIP1	1.47e-04	804	147	16	gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000	MAP2 CTSC CEP290 ZNF205 IKZF1 SIM1 ZFP69 CYP39A1 CIT SLC7A11 SLC1A2 KANSL1 BRCA2 MTIF2 SYNE2 PKP2 ZNF624 ZFHX3	1.70e-04	989	147	18	Facebase_RNAseq_e10.5_Maxillary Arch_1000
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#5_top-relative-expression-ranked_100	CPB2 PKHD1 RBM47	1.70e-04	16	147	3	gudmap_developingKidney_e15.5_100_k5
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	USP49 SHROOM3 ZFP3 MAP2 ZNF569 ZSWIM5 ZNF329 CEP290 MCM2 ZNF205 HIC2 ZSWIM6 SIM1 CCDC77 WDR76 CYP39A1 ZNF773 GTF2H2 BRCA2 SYNE2 KDM1B MYRF	1.89e-04	1370	147	22	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000	MYH8 IKZF2 MAP2 SIM1 PPWD1 ZEB2 CEP170 SYT16 GRHL1 SLC15A2 ZFP91 GIGYF2 INSYN2B ZFHX3 KDM1B VCPIP1	2.29e-04	836	147	16	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FRAS1 SHROOM3 LAMA3 HEATR5A EPB41L3 DSCAML1 SLC15A2 PKHD1 COBL RBM47 MYRF	2.55e-11	177	151	11	9af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FRAS1 SHROOM3 LAMA3 HEATR5A EPB41L3 DSCAML1 SLC15A2 PKHD1 COBL MYRF	5.96e-10	179	151	10	04ce3673e46606f63d9c87bcba3a64c96817d812
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FRAS1 SHROOM3 LAMA3 HEATR5A EPB41L3 DSCAML1 SLC15A2 PKHD1 COBL MYRF	6.64e-10	181	151	10	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	Control-Epithelial_alveolar\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 CTSC LAMA3 EPB41L3 SLC15A2 PKHD1 COBL RBM47 MYRF	1.48e-08	185	151	9	3937e026add96a396122139daf8011cfbc60e75c
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FRAS1 SHROOM3 LAMA3 EPB41L3 DSCAML1 SLC15A2 PKHD1 COBL MYRF	1.55e-08	186	151	9	3aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FRAS1 LAMA3 HEATR5A EPB41L3 DSCAML1 SLC15A2 SYNE2 PKHD1 COBL	2.66e-08	198	151	9	b598ab958e31f1e98bd06dc0097b58ac3a3f90a3
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FRAS1 LAMA3 HEATR5A DSCAML1 SLC15A2 SYNE2 PKHD1 COBL MYRF	2.77e-08	199	151	9	d43c605a4ff221cf78d91678c15d2ad20f831c7f
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FRAS1 LAMA3 HEATR5A EPB41L3 DSCAML1 SLC15A2 SYNE2 PKHD1 COBL	2.77e-08	199	151	9	a270630626df614f8605abddb7dee7c4d74f6149
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / Treatment groups by lineage, cell group, cell type	CEP290 LAMA3 HEATR5A EPB41L3 SLC15A2 SYNE2 PKHD1 COBL MYRF	2.90e-08	200	151	9	2dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FRAS1 LAMA3 HEATR5A EPB41L3 DSCAML1 SLC15A2 SYNE2 PKHD1 COBL	2.90e-08	200	151	9	ddfb1f006365bf16203ee49f20200f68220cc288
ToppCell	Control-Epithelial_alveolar-AT_1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 LAMA3 EPB41L3 DSCAML1 SLC15A2 PKHD1 COBL MYRF	1.76e-07	178	151	8	aa7d43c655df493f1330a5001efaa484e4a19f69
ToppCell	Control-Epithelial_alveolar-AT_1-AT1-AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 LAMA3 EPB41L3 SLC15A2 PKHD1 COBL RBM47 MYRF	2.08e-07	182	151	8	a95956ce4adccb34cc0c47ebfa1878ce4617904e
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FRAS1 SHROOM3 LAMA3 EPB41L3 SYNE2 PKHD1 COBL MYRF	2.27e-07	184	151	8	42ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FRAS1 SHROOM3 LAMA3 EPB41L3 SLC15A2 PKHD1 COBL MYRF	2.36e-07	185	151	8	c82eab551f65ecebe6db908eda9f9eb3414693c7
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FRAS1 SHROOM3 IKZF2 LAMA3 EPB41L3 PKHD1 COBL MYRF	2.46e-07	186	151	8	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FRAS1 SHROOM3 LAMA3 EPB41L3 SYNE2 PKHD1 COBL MYRF	2.56e-07	187	151	8	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	COVID-19-kidney-Proliferating_T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	IKZF3 ANK1 IKZF1 WDR76 CIT NDC80 BRCA2 BUB1B	3.01e-07	191	151	8	bae388e0e9447d576e68465d73d8313ef6925ffa
ToppCell	Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control_saline / Treatment groups by lineage, cell group, cell type	FRAS1 LAMA3 HEATR5A EPB41L3 SLC15A2 SYNE2 PKHD1 COBL	3.96e-07	198	151	8	85f424cd9bb3117c9e322031024aabb87696ce47
ToppCell	Control_saline-Epithelial_alveolar-AT_1\|Control_saline / Treatment groups by lineage, cell group, cell type	FRAS1 LAMA3 HEATR5A EPB41L3 SLC15A2 SYNE2 PKHD1 COBL	3.96e-07	198	151	8	9b161285df7a4e51618f3517cfc5b8221ba55786
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYH1 EPB41L3 WDR76 CIT NDC80 BRCA2 BUB1B ZNF726	4.11e-07	199	151	8	1d5a3366474c17e3df0ba5cf11b586655529e9bd
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FRAS1 LAMA3 HEATR5A SLC15A2 SYNE2 PKHD1 COBL MYRF	4.27e-07	200	151	8	8683445ad5b70748c4a1f12eb77d47623085147e
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-AT1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LAMA3 EPB41L3 DSCAML1 SLC15A2 PKHD1 COBL MYRF	1.32e-06	161	151	7	1e17a993126e1f2a25ee7dfbb95a74ccb2a26791
ToppCell	Control-Epithelial_cells-AT1\|Control / group, cell type (main and fine annotations)	SHROOM3 MAP2 SPTBN1 LAMA3 EPB41L3 COBL MYRF	2.21e-06	174	151	7	548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCell	Control-Epithelial_alveolar-AT_1-AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 LAMA3 EPB41L3 DSCAML1 PKHD1 COBL MYRF	2.57e-06	178	151	7	1817bc520f3d23da8c0fa09bba50ae703a820cb1
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 FRAS1 ANK1 DSCAML1 RYR2 PKHD1 DISP3	3.21e-06	184	151	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 FRAS1 ANK1 DSCAML1 RYR2 PKHD1 DISP3	3.21e-06	184	151	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 FRAS1 ANK1 DSCAML1 RYR2 PKHD1 DISP3	3.21e-06	184	151	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SHROOM3 MAP2 SPTBN1 LAMA3 EPB41L3 COBL MYRF	3.32e-06	185	151	7	1c222f7285d6e3dae0354dc7e853ddc0ea55e63e
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D175\|Adult / Lineage, Cell type, age group and donor	SHROOM3 MAP2 SPTBN1 LAMA3 SLC15A2 COBL MYRF	3.32e-06	185	151	7	32b4e68e551d435a732f253f6ad83408c759a642
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 SIM1 DSCAML1 DNAH17 PKHD1 ZNF69 COBL	3.57e-06	187	151	7	c41a2c81dd2ceef303f39f699032aa7d6ea67cf0
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 SIM1 DSCAML1 DNAH17 PKHD1 ZNF69 COBL	3.96e-06	190	151	7	59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SHROOM3 MAP2 SPTBN1 LAMA3 EPB41L3 COBL MYRF	3.96e-06	190	151	7	30b50d183d7649146eb1e79b47ba897355f1998a
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ATG2B KANSL3 GZF1 KANSL1 BRCA2 PAN2 UGGT2	3.96e-06	190	151	7	3f0c7d130f66faea778fe567604edf1b4cdf85b3
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	LAMA3 CIT SLC1A2 NDC80 BUB1B PKHD1 RBM47	4.24e-06	192	151	7	25378b5e4b0cea8415ff125783511fc25a56fc00
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ATG2B KANSL3 GZF1 KANSL1 BRCA2 PAN2 UGGT2	4.24e-06	192	151	7	c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2
ToppCell	RV-08._Macrophage\|RV / Chamber and Cluster_Paper	IKZF1 ZSWIM6 EPB41L3 ZEB2 BRCA2 BUB1B RBM47	4.39e-06	193	151	7	12bf98a280f87e4d8f0c6887dfc855da72e47ac1
ToppCell	PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	LAMA3 CIT SLC1A2 NDC80 BUB1B PKHD1 RBM47	4.54e-06	194	151	7	c197e4acbff42a9f0410b6801c2bfcf6160aefc1
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA3 SIM1 DSCAML1 SYT16 SYNE2 PKHD1 COBL	4.54e-06	194	151	7	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 SHROOM3 SIM1 DSCAML1 PKHD1 COBL RBM47	4.70e-06	195	151	7	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	COVID-19-T_cells-Cycling_NK/T_cells\|COVID-19 / group, cell type (main and fine annotations)	ANK1 IKZF1 WDR76 CIT NDC80 BRCA2 BUB1B	4.70e-06	195	151	7	764ed100c28d9bc93ee5ecabc5291c8f184d78da
ToppCell	(7)_Epithelial-I_(AT1)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	SHROOM3 MAP2 LAMA3 SYT16 SLC15A2 COBL MYRF	4.86e-06	196	151	7	150554fa06868d29b0608189862eef6505ba757f
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SHROOM3 LAMA3 HEATR5A SLC15A2 SYNE2 PKHD1 COBL	5.02e-06	197	151	7	b94645d57efe8d9e032bffb8c89af1f425c6421e
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW08-Neuronal-GABAergic_neurons\|GW08 / Sample Type, Dataset, Time_group, and Cell type.	SHROOM3 CEP290 ZNF215 DSCAML1 ZNF773 SERPINB13 TUBD1	5.02e-06	197	151	7	e1a80c1aa7f7e83f5d19a40fe37db5c5a6c25685
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 EFCAB13 DSCAML1 SYNE2 PKHD1 COBL RBM47	5.02e-06	197	151	7	7e93a97b5ac5ae2f77a4b3141082a1463fed00dd
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	MCM2 WDR76 CIT NDC80 BRCA2 SYNE2 BUB1B	5.37e-06	199	151	7	305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FRAS1 LAMA3 HEATR5A SLC15A2 SYNE2 PKHD1 COBL	5.37e-06	199	151	7	1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	MCM2 WDR76 CIT NDC80 BRCA2 SYNE2 BUB1B	5.37e-06	199	151	7	101f78fe6dd1bf9e2e4dd5ad8a970312b3540927
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MCM2 WDR76 CIT NDC80 BRCA2 SYNE2 BUB1B	5.37e-06	199	151	7	e0fcec796afe75e42467ca86355b9fc5aa9ae0a1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MCM2 WDR76 CIT NDC80 BRCA2 SYNE2 BUB1B	5.37e-06	199	151	7	fba48342066aab41a8bcb20db40a6df0158e1cbe
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SHROOM3 SLC1A2 PKP2 COBL GNAS RBM47 MGAM2	5.55e-06	200	151	7	7c2d499af60654b7b28f172ac2c914ad49fb74b4
ToppCell	LPS-IL1RA-Endothelial-Epi-like-Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CCDC60 ERCC4 SPTBN1 EPB41L3 ZNF668 SLC15A2	7.72e-06	138	151	6	5f8ac8f67e34a7cf560099208e6884102532391e
ToppCell	AT1-AT2_cells-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	MAP2 ZNF205 PCDHA7 SLC15A2 MROH7 MYRF	1.02e-05	145	151	6	cd5de30fd948024e3ad043c9411ce9f2722178b2
ToppCell	11.5-Distal-RBC\|Distal / Age, Tissue, Lineage and Cell class	ANK1 IKZF1 ZNF101 BTN2A2 MROH7 PKP2	1.99e-05	163	151	6	e9d814952d824539ff1dea119e4fca14a8c335a8
ToppCell	11.5-Distal-RBC-RBC\|Distal / Age, Tissue, Lineage and Cell class	ANK1 IKZF1 ZNF101 BTN2A2 MROH7 PKP2	1.99e-05	163	151	6	31b60e065bac4ad380247964e7574f210106ebae
ToppCell	390C-Lymphocytic-NK_cells-Proliferating_NK_cell\|390C / Donor, Lineage, Cell class and subclass (all cells)	MCM2 WDR76 ZNF442 CIT NDC80 BUB1B	2.52e-05	170	151	6	5319f73cff64f2bb67472c7156ee1d0f006c6fc0
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	SHROOM3 MAP2 SPTBN1 LAMA3 ZFY COBL	2.52e-05	170	151	6	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	390C-Lymphocytic-NK_cells-Proliferating_NK_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	MCM2 WDR76 ZNF442 CIT NDC80 BUB1B	3.06e-05	176	151	6	8813c01ea080f373fe3970c5e1ba4c2dca0f7f02
ToppCell	390C-Lymphocytic-NK_cells-Proliferating_NK_cell\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	ZSWIM5 MCM2 WDR76 CIT NDC80 BUB1B	3.37e-05	179	151	6	e67ad7ab04d0c1309296f57c1f53c5ca14c213fe
ToppCell	Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Pnoc_(Fast-spiking_interneuron,_Pvalb+/Pnoc+)-\|Striatum / BrainAtlas - Mouse McCarroll V32	MYH1 MYH8 PCDHA9 PCDHA7 DISP3	3.67e-05	110	151	5	5496c92932195386025254b9129d69b12c8e3340
ToppCell	Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Pnoc_(Fast-spiking_interneuron,_Pvalb+/Pnoc+)--\|Striatum / BrainAtlas - Mouse McCarroll V32	MYH1 MYH8 PCDHA9 PCDHA7 DISP3	3.67e-05	110	151	5	41306a2d4a5a39569437eb123e47f98ef8afab24
ToppCell	Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Pnoc_(Fast-spiking_interneuron,_Pvalb+/Pnoc+)\|Striatum / BrainAtlas - Mouse McCarroll V32	MYH1 MYH8 PCDHA9 PCDHA7 DISP3	3.67e-05	110	151	5	1fe08060248b25329f73b80d74435c108bee1359
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FRAS1 LAMA3 EPB41L3 PKHD1 PKP2 MYRF	3.70e-05	182	151	6	573771130247e869e4e58f22d4a1cb31989635cf
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 LAMA3 EPB41L3 PKHD1 COBL MYRF	3.70e-05	182	151	6	cc79e0cc21e2fdc4ef77f052818d27b9f707aec1
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FRAS1 LAMA3 EPB41L3 PKHD1 PKP2 MYRF	3.70e-05	182	151	6	6cfaa2b3b3974c13b01c943f4adb70768dcc35e4
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 LAMA3 EPB41L3 SLC15A2 PKHD1 MYRF	3.81e-05	183	151	6	274483009b309289e4cb84beedf6806430db6ff6
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 LAMA3 EPB41L3 PKHD1 COBL MYRF	3.81e-05	183	151	6	ff6dde877659cde9daa3263db0932c9c9ef1adac
ToppCell	AT1-AT2_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	MAP2 LAMA3 CPB2 CIT SLC15A2 MYRF	3.81e-05	183	151	6	6821dca076318115d360ff426eb1218cfe104063
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SHROOM3 MAP2 SPTBN1 LAMA3 COBL MYRF	3.93e-05	184	151	6	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	COPD-Myeloid-cMonocyte\|World / Disease state, Lineage and Cell class	ZSWIM6 EPB41L3 ZEB2 LATS2 PCNX1 RBM47	3.93e-05	184	151	6	ceec41ed5636032aaf7716d1203816ea58bd39bd
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 LAMA3 EPB41L3 PKHD1 COBL MYRF	3.93e-05	184	151	6	cdf6f1c6cce97a7effa0c55959652e2c0b6992b3
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SHROOM3 MAP2 SPTBN1 LAMA3 COBL MYRF	3.93e-05	184	151	6	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	Control-T_cells-Cycling_NK/T_cells\|Control / group, cell type (main and fine annotations)	IKZF3 WDR76 CIT NDC80 BRCA2 BUB1B	4.05e-05	185	151	6	9766216b41ee62bbac4caa25cb98ec5627a24075
ToppCell	LPS_only-Epithelial_alveolar-AT_1-AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 LAMA3 EPB41L3 PKHD1 COBL MYRF	4.05e-05	185	151	6	0c247a3f394c42e2a6f67fee3d9cf33096fecd13
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZFP69 SLC7A11 SLC1A2 ZNF568 BTN2A2 LTV1	4.17e-05	186	151	6	a558fd00053e7dd6216b01dc8e650c30cee451f1
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZFP69 SLC7A11 SLC1A2 ZNF568 BTN2A2 LTV1	4.17e-05	186	151	6	75b1f342be5d6dbe0e7acd924a0ca75964f6bab0
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZFP69 SLC7A11 SLC1A2 ZNF568 BTN2A2 LTV1	4.17e-05	186	151	6	0c3d195077de7b4c354c127a26116438aef29244
ToppCell	368C-Myeloid-Dendritic-cDC_proliferating_1\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	MCM2 WDR76 CIT SLC7A8 BUB1B ZNF615	4.17e-05	186	151	6	5cadab3271fce9ab6da3d7ba9827b8a221cac166
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SHROOM3 MAP2 SPTBN1 LAMA3 COBL MYRF	4.30e-05	187	151	6	d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2
ToppCell	LPS_only-Epithelial_alveolar-AT_1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FRAS1 SHROOM3 LAMA3 EPB41L3 PKHD1 MYRF	4.30e-05	187	151	6	ff26a533d310126521efe1d05cf8b9d32e524550
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1\|Adult / Lineage, Cell type, age group and donor	SHROOM3 MAP2 SPTBN1 LAMA3 COBL MYRF	4.30e-05	187	151	6	77f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IKZF1 SAMHD1 WDR76 NDC80 BRCA2 BUB1B	4.30e-05	187	151	6	73931a5ea73799095daff100b5f18853c57c74dc
ToppCell	COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int\|COVID-19 / Disease (COVID-19 only), tissue and cell type	IKZF3 IKZF1 ZNF215 SLC7A11 SLC15A2 BUB1B	4.43e-05	188	151	6	599195338070ac6b79bd114609d9e10cac4f1df4
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SHROOM3 MAP2 LAMA3 MPRIP COBL MYRF	4.43e-05	188	151	6	43a3a59f92ad93509d4166bd025aed0b1b39a008
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D231\|Adult / Lineage, Cell type, age group and donor	SHROOM3 MAP2 SPTBN1 LAMA3 COBL MYRF	4.56e-05	189	151	6	5a04cb25f8f0447b2cecdb6c3695029281aca26d
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 SIM1 DSCAML1 DNAH17 PKHD1 COBL	4.70e-05	190	151	6	1cf023e3c6924d6a06f353d4b62444b6f2fee8a7
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	FRAS1 IKZF2 LAMA3 SLC1A2 PKHD1 RBM47	4.70e-05	190	151	6	625c08a0e5227efc46daa512fd579c3938ff76c7
ToppCell	PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	LAMA3 CIT SLC1A2 NDC80 BUB1B PKHD1	4.84e-05	191	151	6	39220f4a345e328f7fa4fd462a0abeea821b3e02
ToppCell	LAM-Epithelial-AT1\|LAM / Condition, Lineage and Cell class	SHROOM3 MAP2 SPTBN1 LAMA3 COBL MYRF	4.84e-05	191	151	6	66875b2ec2c510489407f3e433a90cdf74a15094
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SHROOM3 LAMA3 PKHD1 COBL RBM47 MYRF	4.84e-05	191	151	6	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 SHROOM3 ZSWIM6 EPB41L3 SYNE2 PKHD1	4.98e-05	192	151	6	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ZSWIM6 EPB41L3 ZEB2 KANSL1 PCNX1 RBM47	5.12e-05	193	151	6	779276e775cb2492e8dd36436295a536084a6415
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	ZNF845 HEATR5A ZFP91 GIGYF2 PCNX1 KDM1B	5.12e-05	193	151	6	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	Fetal_29-31_weeks-Epithelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SHROOM3 LAMA3 PKHD1 COBL RBM47 MYRF	5.12e-05	193	151	6	a0ca3231992f14abcf1a6129573bace320e89d2a
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MCM2 WDR76 CIT NDC80 BRCA2 BUB1B	5.27e-05	194	151	6	f39a471293ecc5c5967b00e772b8f48ebc9affbe
ToppCell	Control-Lymphoid_T/NK-T/NK_proliferative\|Control / Disease group, lineage and cell class	MCM2 WDR76 CIT NDC80 BRCA2 BUB1B	5.27e-05	194	151	6	9bbb124001fba7450f4639f47f9b720a483e7242
ToppCell	COPD-Myeloid-Macrophage\|World / Disease state, Lineage and Cell class	ZSWIM6 EPB41L3 ZEB2 PKP2 PCNX1 RBM47	5.27e-05	194	151	6	7d682408e9a6239a4e47befc9376e760cc3d133a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 SHROOM3 SIM1 PKHD1 COBL RBM47	5.27e-05	194	151	6	93c68c31e39fa44c1d05d7d4997f4f086da4e738
ToppCell	Control-Lymphocyte-T_NK-T_NK_proliferative\|Control / Disease, Lineage and Cell Type	MCM2 WDR76 CIT NDC80 BRCA2 BUB1B	5.27e-05	194	151	6	844731b7943d1cfca819b7b89e4e62067bfa0230
ToppCell	LA-08._Macrophage\|World / Chamber and Cluster_Paper	IKZF1 ZSWIM6 EPB41L3 ZEB2 BRCA2 RBM47	5.27e-05	194	151	6	c1805572bcc11b1cd29083329d7b5911489fb758
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 SHROOM3 SIM1 PKHD1 COBL RBM47	5.27e-05	194	151	6	5eaaa81f4b2535f983c424aaef00077089526a5c
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH1 MYH4 MYH8	1.36e-05	10	145	3	DOID:0111269 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH1 MYH4 MYH8	1.36e-05	10	145	3	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH1 MYH4 MYH8	1.36e-05	10	145	3	DOID:0111596 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH1 MYH4 MYH8	1.36e-05	10	145	3	DOID:0110454 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH1 MYH4 MYH8	1.36e-05	10	145	3	DOID:0080719 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH1 MYH4 MYH8	1.36e-05	10	145	3	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH1 MYH4 MYH8	1.36e-05	10	145	3	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH1 MYH4 MYH8	1.36e-05	10	145	3	DOID:0080326 (implicated_via_orthology)
Disease	eosinophil percentage of granulocytes	IKZF3 IKZF2 IKZF1 IKZF4 KANSL3 SERPINB13 KANSL1 TUBD1	2.17e-05	234	145	8	EFO_0007996
Disease	distal myopathy (implicated_via_orthology)	MYH1 MYH4 MYH8	2.48e-05	12	145	3	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH1 MYH4 MYH8	2.48e-05	12	145	3	DOID:2106 (implicated_via_orthology)
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH1 MYH4 MYH8	3.21e-05	13	145	3	DOID:397 (implicated_via_orthology)
Disease	Colorectal Carcinoma	MAP2 ZNF569 AKAP3 ZNF442 DSCAML1 ZEB2 EIF4G1 BUB1B PKHD1 PAN2 ZNF432 ZNF624 GNAS	4.57e-05	702	145	13	C0009402
Disease	distal arthrogryposis (implicated_via_orthology)	MYH1 MYH4 MYH8	5.06e-05	15	145	3	DOID:0050646 (implicated_via_orthology)
Disease	Arrhythmogenic Right Ventricular Dysplasia	RYR2 PKP2	7.17e-05	3	145	2	C0349788
Disease	blood urea nitrogen measurement	SHROOM3 IKZF2 SIM1 GRHL1 SLC15A2 BUB1B PKHD1 UGGT2 GNAS RBM47	8.44e-05	452	145	10	EFO_0004741
Disease	apolipoprotein B measurement	ANK1 ZNF329 EFCAB13 ZNF101 SIM1 PTPN11 BRCA2 SYNE2 ZFHX3 PISD RBM47 MYRF	1.12e-04	663	145	12	EFO_0004615
Disease	event-related brain oscillation	KANSL3 GNAS	1.43e-04	4	145	2	EFO_0004358
Disease	QRS-T angle	CCDC60 SPTBN1 RYR2 KANSL1 PCNX1	1.82e-04	106	145	5	EFO_0020097
Disease	Malignant neoplasm of breast	MYH1 ANK1 ZNF569 ZSWIM5 EFCAB13 RECQL SIM1 EPB41L3 ZEB2 ZNF668 BRCA2 SYNE2 ZNF432 MROH7 SMOX	2.73e-04	1074	145	15	C0006142
Disease	MYELODYSPLASTIC SYNDROME	ERCC4 SAMD9 PTPN11 BRCA2	3.37e-04	67	145	4	C3463824
Disease	1,5 anhydroglucitol measurement	PCDHA9 PCDHA7 MGAM2	3.87e-04	29	145	3	EFO_0008009
Disease	dilated cardiomyopathy (implicated_via_orthology)	MYH1 MYH4 MYH8 PTPN11	6.62e-04	80	145	4	DOID:12930 (implicated_via_orthology)
Disease	insulin response measurement	ANK1 IKZF1	8.44e-04	9	145	2	EFO_0008473
Disease	Malignant tumor of prostate	BRCA2 ZFHX3	8.44e-04	9	145	2	cv:C0376358
Disease	neutrophil percentage of granulocytes	IKZF3 IKZF2 IKZF1 IKZF4 KANSL3 KANSL1	9.49e-04	228	145	6	EFO_0007994
Disease	eosinophil count	IKZF3 IKZF2 HIVEP1 CTSC SPTBN1 IKZF1 SLC7A11 ZNF568 IKZF4 KANSL3 PTPN11 SERPINB13 KANSL1 ZBTB40 PCNX1 TUBD1 MYRF	1.05e-03	1488	145	17	EFO_0004842
Disease	triacylglycerol 54:1 measurement	SAMHD1 ZNF432	1.05e-03	10	145	2	EFO_0010419
Disease	arrhythmogenic right ventricular cardiomyopathy (is_implicated_in)	RYR2 PKP2	1.05e-03	10	145	2	DOID:0050431 (is_implicated_in)
Disease	colorectal cancer (is_marker_for)	ERCC4 LATS2 NDC80 BRCA2 ZFHX3	1.10e-03	157	145	5	DOID:9256 (is_marker_for)
Disease	sunburn	USP49 ERCC4 CTSC CEP290	1.31e-03	96	145	4	EFO_0003958
Disease	basophil percentage of leukocytes	IKZF2 CTSC SPTBN1 IKZF1 SLC7A8 TUBD1	1.32e-03	243	145	6	EFO_0007992
Disease	red blood cell density measurement	USP49 SHROOM3 HIVEP1 ANK1 SPTBN1 NOX3 IKZF1 ZEB2 KANSL1 PKHD1 ZBTB40 MYRF	1.39e-03	880	145	12	EFO_0007978
Disease	Alzheimer disease, educational attainment	SAMD9 ZSWIM6 IKZF4 CEP170 KANSL1 PISD	1.43e-03	247	145	6	EFO_0011015, MONDO_0004975
Disease	Neuroblastoma	DBH PTPN11 GNAS	1.61e-03	47	145	3	C0027819
Disease	myopathy (implicated_via_orthology)	MYH1 MYH4 MYH8	1.71e-03	48	145	3	DOID:423 (implicated_via_orthology)
Disease	survival time, breast carcinoma	KCNH7 ZFHX3	1.81e-03	13	145	2	EFO_0000305, EFO_0000714
Disease	L2 Acute Lymphoblastic Leukemia	IKZF3 IKZF2 IKZF1	1.92e-03	50	145	3	C0023453
Disease	mean reticulocyte volume	USP49 SAMD9 ANK1 MCFD2 IKZF1 PTPN11 KANSL1 ZBTB40 SMOX TUBD1 EPB41L2	2.04e-03	799	145	11	EFO_0010701
Disease	Childhood Acute Lymphoblastic Leukemia	IKZF3 IKZF2 IKZF1	2.15e-03	52	145	3	C0023452
Disease	bone fracture	RPS6KA5 SPTBN1 ZBTB40 COBL	2.30e-03	112	145	4	EFO_0003931
Disease	Germ Cell Cancer	ERCC4 BUB1B	2.41e-03	15	145	2	C0740345
Disease	Embryonal Neoplasm	ERCC4 BUB1B	2.41e-03	15	145	2	C0027654
Disease	Neoplasms, Germ Cell and Embryonal	ERCC4 BUB1B	2.41e-03	15	145	2	C0027658
Disease	Germ cell tumor	ERCC4 BUB1B	2.41e-03	15	145	2	C0205851
Disease	Neoplasms, Embryonal and Mixed	ERCC4 BUB1B	2.41e-03	15	145	2	C0205852
Disease	Gastro-enteropancreatic neuroendocrine tumor	IKZF3 IKZF1	2.41e-03	15	145	2	C2930967
Disease	Cancer, Embryonal	ERCC4 BUB1B	2.41e-03	15	145	2	C0751364
Disease	Cancer, Embryonal and Mixed	ERCC4 BUB1B	2.41e-03	15	145	2	C0751365
Disease	Nasal Cavity Polyp	MIA3 GIGYF2 MYRF	2.53e-03	55	145	3	EFO_1000391
Disease	brain volume measurement	FRAS1 EFCAB13 ZSWIM6 PPWD1 DSCAML1 KANSL1 PKHD1 OSBPL9 ZFHX3	2.79e-03	595	145	9	EFO_0006930
Disease	Alzheimer's disease (implicated_via_orthology)	HIVEP1 PITRM1 MAP2	2.80e-03	57	145	3	DOID:10652 (implicated_via_orthology)
Disease	spine bone mineral density	RPS6KA5 SPTBN1 LYSMD4 ZBTB40	2.87e-03	119	145	4	EFO_0007701
Disease	sphingomyelin 14:0 measurement	SYNE2 ZFHX3	3.11e-03	17	145	2	EFO_0010390
Disease	alcohol consumption measurement	KCNH7 ERCC4 RPS6KA5 SPTBN1 SAMHD1 LYSMD4 CCDC77 WDR76 CIT KANSL1 EIF4G1 PKHD1 COBL ZFHX3	3.30e-03	1242	145	14	EFO_0007878
Disease	Precursor Cell Lymphoblastic Leukemia Lymphoma	IKZF3 IKZF2 IKZF1	3.40e-03	61	145	3	C1961102
Disease	Tachycardia	RYR2 GNAS	3.48e-03	18	145	2	C0039231
Disease	Tachyarrhythmia	RYR2 GNAS	3.48e-03	18	145	2	C0080203
Disease	cystatin C measurement	SHROOM3 ZNF337 ACP1 PTPN11 PKHD1 GNAS RBM47	3.83e-03	402	145	7	EFO_0004617
Disease	tea consumption measurement	MIA3 NOX3 PKHD1 ZFHX3	3.83e-03	129	145	4	EFO_0010091
Disease	sensorineural hearing loss (implicated_via_orthology)	SLC7A8 DNAH17	3.88e-03	19	145	2	DOID:10003 (implicated_via_orthology)
Disease	Tinnitus	SPTBN1 SYT16 NDC80 PKHD1	3.94e-03	130	145	4	HP_0000360
Disease	household income	SAMD9 NOX3 ZSWIM6 IKZF4 KANSL1 PCNX1	4.01e-03	304	145	6	EFO_0009695
Disease	exercise test	CCDC60 RYR2	4.30e-03	20	145	2	EFO_0004328
Disease	heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease, cancer	GRHL1 ZFHX3	4.30e-03	20	145	2	EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004352, MONDO_0004992
Disease	pars triangularis volume measurement	SPTBN1 EPB41L2	4.30e-03	20	145	2	EFO_0010321
Disease	attention deficit hyperactivity disorder (is_implicated_in)	ACP1 DBH	4.30e-03	20	145	2	DOID:1094 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
EMLHKAEIVHGDLSP	BUB1B	871	O60566
RHSGKLEPMEATAHL	GNAS	21	P84996
VMEERKPLTTSGFHH	CEP170	556	Q5SW79
ELLPTDGMIRKHSHV	ABCF2	446	Q9UG63
VTIHEIERKIMDHPG	DISP3	296	Q9P2K9
MTAHIRTHTGEKPFT	CTCFL	501	Q8NI51
KVETPLHMAARAGHT	ANK1	436	P16157
QPSALKTHMRIHTGE	GZF1	446	Q9H116
DKIGKVLPVMHESHH	CCDC77	326	Q9BR77
ILHVHPVEGSETMTL	DNHD1	331	Q96M86
RVHHGEELHMPITVI	DISP1	776	Q96F81
SVHLMGYVHRDIKPE	CIT	211	O14578
EVPIRLDYHGKHVSM	ATG2B	1816	Q96BY7
MRHHISVVKGDAEEI	CCDC60	436	Q8IWA6
LSHHDPIMKVLSIRG	MROH7	1011	Q68CQ1
APKMIEDGKIHTVEH	RBM47	461	A0AV96
EDGKIHTVEHMISPI	RBM47	466	A0AV96
GHMDFEESRAHKIPV	PCDHA9	306	Q9Y5H5
GSVEEHKSVIMHLLS	OSBPL9	366	Q96SU4
REGHLPSVLAMIHVK	SLC7A8	346	Q9UHI5
VSMAGPRLEIHHRFK	MCM2	186	P49736
GHMDFEESRAHKIPV	PCDHA7	306	Q9UN72
VGREEEPHLHMVSKK	PAN2	476	Q504Q3
GLPMSDLKTHNVHVE	MPRIP	621	Q6WCQ1
GQFVMEHHTLPEVKS	FRAS1	3546	Q86XX4
VLHHMVKISGGPRIS	MAGEA6	286	P43360
MSVPGKTHRAIADHL	LTV1	216	Q96GA3
VKIPVRNHGILMETH	LYSMD4	116	Q5XG99
HPVMVDLSGREVELH	LAMA3	931	Q16787
HIMEHLEGVINKPEA	MCFD2	51	Q8NI22
PVVTIMGHVDHGKTT	MTIF2	181	P46199
LMHKAHVEGSTVVRP	MGAM2	1576	Q2M2H8
SVHKMGFIHRDIKPD	LATS2	781	Q9NRM7
VPTSGRMHIDKRSHS	KCNH7	971	Q9NS40
EQHPDMSVTRVVVHK	EPB41L2	981	O43491
RRKGAMVVSVEPHRH	FBLL1	91	A6NHQ2
MVVSVEPHRHEGVFI	FBLL1	96	A6NHQ2
TKTPGAMEHELVLHQ	MYH8	681	P13535
VVPGIRMSIKLHQDH	PCNX1	1851	Q96RV3
PVIGVSMVHRFGKHL	OR51L1	256	Q8NGJ5
THRQHLDDVGAVPMV	KANSL1	746	Q7Z3B3
RKLVSAVSHMHDVGV	RPS6KA5	526	O75582
ETKTPGAMEHELVLH	MYH1	681	P12882
EVHHKQESIMDAGPV	PTPN11	441	Q06124
VLMVHKRSHTGERPF	IKZF1	131	Q13422
VLMVHKRSHTGERPF	IKZF2	126	Q9UKS7
AMHKVQRPGESSHLR	SBF1	486	O95248
SDHLKGLHVMVPDIV	SBF1	846	O95248
REMSVDVPLEVHGLH	FRMD1	411	Q8N878
GPELMLHVKSVFRHA	IDH3G	66	P51553
MTLGPAVVSHHLARV	HEATR5A	561	Q86XA9
EGIHHPISKVRSVIM	GRHL1	291	Q9NZI5
LEHSKAALSVHVPGM	KDM1B	251	Q8NB78
LQEHRAKGVSIPLMH	GIGYF2	516	Q6Y7W6
PDGTIKDRRLFMHHV	BRCA2	2311	P51587
ITERHPDMLTKIHIG	CPB2	136	Q96IY4
LKHVEHPVMSGAEAK	DNAH17	606	Q9UFH2
ELGRKEMEPKSHHTL	CEP290	1521	O15078
AIPVSMDGHRLIHTN	DSCAML1	1331	Q8TD84
PKQVEVRMHDSHLGS	SLC1A2	11	P43004
MGHVRVPAAHTTEVT	COBL	841	O75128
PIVTKGNEALVHHME	DBH	251	P09172
KLELVHHGPMAVAFE	CTSC	361	P53634
TAIDEMLKLGNHPVH	C1RL	306	Q9NZP8
VMLRHVPEHESGKVS	EFCAB13	871	Q8IY85
LASHTVEIHEPNGMV	EIF4G1	351	Q04637
EHMIGAVRSKVLEIH	KANSL3	326	Q9P2N6
SHPDIHKAIMEGISS	CYP39A1	291	Q9NYL5
IPISKAHEHIFGMVL	FAH	216	P16930
MAGHPKERVVTDEVH	FAM183BP	1	Q6ZVS7
NVLMVHKRSHTGERP	IKZF3	131	Q9UKT9
MVPEEGLKLHRVGTH	BTN2A2	506	Q8WVV5
TEDMRGPADKHIPHI	SLC15A2	701	Q16348
DITIDHHKIMHGVAP	S100A7L2	81	Q5SY68
HRPVLMAVSVHSERK	SCNN1D	276	P51172
LMKTAHGHLVPDRVD	RYR2	1346	Q92736
KVIELHKSHRGMTPA	EPB41L3	266	Q9Y2J2
PNVLMVHKRSHTGER	IKZF4	171	Q9H2S9
LTEHMRVHSGEKPYE	HIC2	576	Q96JB3
LKHMPGHTSREVLII	GTF2H2C;	156	Q6P1K8
PNIAKEMHVGHLRST	RARS1	201	P54136
KHKDREVVMEHPSSG	TATDN2	316	Q93075
LSHLHPEGEMKVTLV	SYT16	456	Q17RD7
HLKHGEVILENIRPM	SYNE2	3926	Q8WXH0
HVDTMKVINDPIHGH	SAMHD1	111	Q9Y3Z3
AAIHISKGMLHEEKP	MIA3	531	Q5JRA6
KEHLVDMGITHGPAI	SAMD9	51	Q5K651
IHTSMGDIHTKLFPV	PPWD1	496	Q96BP3
HVPHGSQVIRKLVME	PITRM1	831	Q5JRX3
RHGIPMSHVARQITK	ACP1	66	P24666
DHIQQREGKMLSPHE	SIM1	631	P81133
KVTIARERHMPGAAH	SHROOM3	1576	Q8TF72
ETKTPGAMEHELVLH	MYH4	681	Q9Y623
RFIHEMPGHEETLKA	PKHD1	3596	P08F94
AQGSPHDIIRIEHTM	METTL22	161	Q9BUU2
GTIYHHMPVLRQKEE	MROH2B	1051	Q7Z745
TKVVSHPSGVLELHM	NOX3	296	Q9HBY0
IARQLMHSGHPSEKE	SPTBN1	911	Q01082
KGTPERLHFEMTHKE	AKAP3	91	O75969
LERTKPTVVGVDTHM	C10orf55	11	Q5SWW7
SHLPELHMFQTEGKI	ZNF845	146	Q96IR2
MGIDKPDVRFVIHHS	RECQL	376	P46063
SMLIAHQRTHTGEKP	ZNF615	581	Q8N8J6
SLPSVRRHMIKHTGD	ZNF564	376	Q8TBZ8
SREGHLPEILSMIHV	SLC7A11	346	Q9UPY5
HGPRHEESIMNIIRK	TUBD1	111	Q9UJT1
VSMGHSRSKPHVIAL	ZNF30	51	P17039
LEPAETHSMVRHKDG	RIN2	46	Q8WYP3
SDFTVHLRMHTGEKP	ZNF624	821	Q9P2J8
IHERTEKHIRMPSGE	ZNF700	491	Q9H0M5
GEVIHRESVPMHTFA	ZSWIM5	726	Q9P217
NSFRTHEMIHTGEKP	ZNF136	461	P52737
KLAIHMRSHTGERPF	ZSCAN5DP	366	P0CG00
DLRKHERTHPVPMGT	ZNF668	586	Q96K58
LIIHMRSHTGEKPFE	ZNF568	601	Q3ZCX4
TSPGHMEERKVNLHL	SERPINB13	271	Q9UIV8
LKHMPGHTSREVLII	GTF2H2	156	Q13888
KFLTPGLTHTMERHV	SMRP1	41	Q8NCR6
GLTHTMERHVDPEAL	SMRP1	46	Q8NCR6
ITKPVHKHREMRGLT	RPL15	151	P61313
THTNREGVPMRKGEH	PISD	356	Q9UG56
AHHIIPSGFMRVVEL	SMOX	231	Q9NWM0
KHFEETGHPLAMEVR	USP49	56	Q70CQ1
FMDKHGIHPSLVADV	VCPIP1	421	Q96JH7
SSFRMHERIHTGEKP	ZNF709	461	Q8N972
PKDAHIPVVEEHVMG	MAP2	391	P11137
SSLMKHQRVHTGERP	ZNF773	316	Q6PK81
LTDHQVMHTGEKPHR	ZNF350	221	Q9GZX5
QPSALTIHKRMHIGE	ZNF726	296	A6NNF4
PSLFRMHERTHTGEK	ZNF442	221	Q9H7R0
GEIIHRESVPMHTFA	ZSWIM6	756	Q9HCJ5
RHEKIHTTGPKALAM	ZNF205	521	O95201
LRRHEMTHTGEKPFD	ZNF101	381	Q8IZC7
TSLIVHMRGHTGEKP	ZNF569	591	Q5MCW4
GSMAHPRRVEIFHET	WDR76	566	Q9H967
SRMIEHQRTHTGEKP	ZNF432	386	O94892
ASVLRMHGRTHPEDK	ZNF69	546	Q9UC07
SLIRHQMIHTGEKPF	ZNF215	476	Q9UL58
SKLVIHRRMHTGEKP	ZNF528	226	Q3MIS6
NRTGKPVHSMVAHLD	STRN4	666	Q9NRL3
NLAVHRMIHTGEKPL	ZFP91	386	Q96JP5
QHKPEVVEIHVSMTP	ERCC4	206	Q92889
NKPAVVDTIVMAHHG	UGGT2	1116	Q9NYU1
LERHMVTHKPGTDQH	ZEB2	256	O60315
HSMEVIHGRNPVREK	ZNF329	131	Q86UD4
LQHTRKMLHVGDPSV	PKP2	731	Q99959
SNLTEHMRIHTGEKP	ZNF680	391	Q8NEM1
SALKIHMRVHTGERP	ZNF317	291	Q96PQ6
HDLGAMELQPVHIIK	HIVEP1	506	P15822
SHIHLVARGPEQTMD	HIVEP1	1091	P15822
SMLERHVVTHVGGKP	ZBTB40	991	Q9NUA8
QLMHKALDRVEEHPG	UBXN11	311	Q5T124
LTIHQRTHSGEKPFM	ZNF337	531	Q9Y3M9
PSELRKHMRIHTGEK	ZFY	556	P08048
LTEHMRIHTGEKPFR	ZFP69	286	Q49AA0
LIQHMRVHSGEKPFE	ZFP3	156	Q96NJ6
PTRKMLDHIAHEVGL	ZFHX3	2666	Q15911
DPAVMGKTQATRHHL	INSYN2B	61	A6NMK8
GSLMHPSDLRAKEHV	MYRF	581	Q9Y2G1
LEMVATHVGSVEKHL	NDC80	586	O14777